Literature DB >> 15143957

Lipids in ischemic stroke subtypes.

P Laloux1, L Galanti, J Jamart.   

Abstract

In secondary prevention, reduction of the risk of recurrent ischemic stroke might be expected with statins if a correlation can be established between hyperlipidemia and ischemic stroke or some specific ischemic stroke/TIA subtypes. However, such correlation remains controversial, and more particularly with the etiologic stroke/TIA subtypes. Few studies have evaluated the plasma lipid profile in different ischemic stroke subtypes, and notably in lacunar infarctions and cardioembolic strokes. The objectives of this case-control study was to determine (1) which cholesterol fractions is associated with large vessel disease (LVD), small vessel disease (SVD), and cardioembolic disease (CED); (2) whether hypertriglyceridemia is related more to any particular stroke subtype; and (3) whether the lipid profile is different between LVD and SVD which are both responsible for atherothrombotic cerebral ischemia. From a cohort of 485 patients, were selected 240 consecutive cases with ischemic stroke (n = 182) or transient ischemic attack (n = 58) due to a single etiology. The levels of total cholesterol (total-C), LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C), and triglycerides (TG) were measured in 61 patients with LVD, in 65 with SVD, and in 114 with CED, and compared with age- and sex-matched control subjects. Additional analysis was performed to compare the lipid profile between LVD and SVD after adjustment for other risk factors. Compared to controls, the total-C level was significantly higher in patients with SVD (p = 0.005) and LVD (p = 0.018). A significant increase in the LDL-C level (p < 0.004) and a significant decrease in the HDL-C level (p = 0.001) were only observed in the LVD patients. The three stroke subtypes showed higher TG levels than the controls (CED, p = 0.037; SVD, p < 0.001; LVD, p = 0.014). The plasma lipid profile was similar in the SVD and LVD subtypes except for HDL-C, which was significantly lower in LVD than in SVD (p = 0.047). Logistic regression adjusted for confounders showed that decreased HDL-C (p = 0.020), and smoking (p = 0.019) were significant discriminative factors for LVD vs. SVD. In conclusion, this controlled study shows that hypertriglyceridemia is commonly found in patients with ischemic cerebrovascular disease whatever the etiologic subtype, whereas hypercholesterolemia is related more to SVD and LVD. In addition to hypertension and diabetes, hypercholesterolemia may also be involved in the etiology of SVD and differs from LVD by a lower decrease in HDL-C.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143957

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  17 in total

1.  Stroke: hyperlipidemia and cerebral small-vessel disease.

Authors:  Jessica R L Warsch; Clinton B Wright
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

2.  Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study.

Authors:  Aleksandra Pikula; Alexa S Beiser; Jing Wang; Jayandra J Himali; Margaret Kelly-Hayes; Carlos S Kase; Qiong Yang; Sudha Seshadri; Philip A Wolf
Journal:  Neurology       Date:  2015-01-07       Impact factor: 9.910

Review 3.  The role of statins in the prevention of ischemic stroke.

Authors:  Bo Ziedén; Anders G Olsson
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

Review 4.  The role of cholesterol and statins in stroke.

Authors:  Babak B Navi; Alan Z Segal
Journal:  Curr Cardiol Rep       Date:  2009-01       Impact factor: 2.931

5.  LDL Subclasses in Ischemic Stroke: A Risk Factor?

Authors:  Yusuf Kayran; Vildan Yayla; Murat Çabalar; Arsida Bajrami; Yasemin Karamanli; Asuman Gedikbaşi; Zülkif Tanriverdİ
Journal:  Noro Psikiyatr Ars       Date:  2018-07-05       Impact factor: 1.339

6.  Clinical symptoms and risk factors in cerebral microangiopathy patients.

Authors:  Sandra Okroglic; Catherine N Widmann; Horst Urbach; Philip Scheltens; Michael T Heneka
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

7.  The role of fasting versus non-fasting triglycerides in ischemic stroke: a systematic review.

Authors:  Christopher Leonards; Martin Ebinger; Jana Batluk; Uwe Malzahn; Peter Heuschmann; Matthias Endres
Journal:  Front Neurol       Date:  2010-10-25       Impact factor: 4.003

8.  The Triglyceride Paradox in Stroke Survivors: A Prospective Study.

Authors:  Minal Jain; Anunaya Jain; Neeraja Yerragondu; Robert D Brown; Alejandro Rabinstein; Babak S Jahromi; Lekshmi Vaidyanathan; Brian Blyth; Latha Ganti Stead
Journal:  Neurosci J       Date:  2013-02-25

9.  Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis.

Authors:  Piotr Musialek; Wieslawa Tracz; Lukasz Tekieli; Piotr Pieniazek; Anna Kablak-Ziembicka; Tadeusz Przewlocki; Ewa Stepien; Przemyslaw Kapusta; Rafal Motyl; Jakub Stepniewski; Anetta Undas; Piotr Podolec
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

10.  Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patients.

Authors:  Qiang Wei; Honghao Wang; Yanghua Tian; Fangcheng Xu; Xianwen Chen; Kai Wang
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.